共 50 条
- [1] Development and preclinical assessment of a first-in-class small-molecule inhibitor of FLIPMOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)Higgins, Catherine A.Majkut, JoannaFox, JenniferHumphreys, LukeFiedler, Greti EsponaBoffey, Ray J.Perrior, Trevor R.Haigh, DavidHarrison, TimothyLongley, Daniel B.
- [2] Development and preclinical assessment of a first-in-class small molecule inhibitor of the major cell death regulator protein FLIPCANCER RESEARCH, 2015, 75Majkut, JoannaHiggins, CatherineMaliki, AdnanNemeth, ZsusannahBlurton, PeterBoffey, RayPerrior, Trevor R.Johnston, Patrick G.Haigh, DavidHarrison, TimothyLongley, Daniel B.
- [3] Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIPCANCER RESEARCH, 2019, 79 (13)Higgins, Catherine A.Fox, JenniferMajkut, JoannaFiedler, Greti E.Roberts, JamieHumphreys, LukeBoffey, Ray J.Perrior, Trevor R.Harrison, TimothyLongley, Daniel B.
- [4] Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP for treatment of NSCLC and CRCEUROPEAN JOURNAL OF CANCER, 2016, 69 : S6 - S6Higgins, C. A.Majkut, J.Humphreys, L.Fox, J.Espona-Fiedler, M.Malik, A.Nemeth, Z.Blurton, P.Boffey, R. J.Perrior, T. R.Haigh, D.Harrison, T.Longley, D. B.
- [5] Development and preclinical evaluation of unique first-in-class small molecule inhibitors of the anti-apoptotic protein FLIP.CANCER RESEARCH, 2021, 81 (13)Higgins, Catherine A.Fox, JenniferRoberts, JamieDoherty, DeclanPerrior, TrevorBoffey, RayHarrison, TimLongley, Daniel B.
- [6] Development and characterization of a first-in-class small molecule inhibitor of PELP1CANCER RESEARCH, 2020, 80 (04)Altwegg, Kristin A.Viswanadhapalli, SuryavathiMann, MonicaPratap, Uday P.Li, MengxingLiu, JunhaoLuo, YiliaoSareddy, Gangadhara R.Vankayalapati, HariprasadVadlamudi, Ratna K.
- [7] Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 DimerizationACS CENTRAL SCIENCE, 2022, 8 (05) : 636 - 655Bhatia, SanilSpanier, LukasBickel, DavidDienstbier, NiklasWoloschin, VitalijVogt, MelinaPols, HenrikLungerich, BeateReiners, JensAghaallaei, NargesDiedrich, DanielaFrieg, BenediktSchliehe-Diecks, JulianBopp, BertanLang, FranziskaGopalswamy, MohanrajLoschwitz, JenniferBajohgli, BaubakSkokowa, JuliaBorkhardt, ArndtHauer, JuliaHansen, Finn K.Smits, Sander H. J.Jose, JoachimGohlke, HolgerKurz, Thomas
- [8] First-in-class small molecule potentiators of cancer virotherapyScientific Reports, 6Mark H. DornanRamya KrishnanAndrew M. MacklinMohammed SelmanNader El SayesHwan Hee SonColin DavisAndrew ChenKerkeslin KeillorPenny J. LeChristina MoiPaula OuChristophe PardinCarlos R. CanezFabrice Le BoeufJohn C. BellJeffrey C. SmithJean-Simon DialloChristopher N. Boddy
- [9] First-in-class small molecule potentiators of cancer virotherapySCIENTIFIC REPORTS, 2016, 6Dornan, Mark H.Krishnan, RamyaMacklin, Andrew M.Selman, MohammedEl Sayes, NaderSon, Hwan HeeDavis, ColinChen, AndrewKeillor, KerkeslinLe, Penny J.Moi, ChristinaOu, PaulaPardin, ChristopheCanez, Carlos R.Le Boeuf, FabriceBell, John C.Smith, Jeffrey C.Diallo, Jean-SimonBoddy, Christopher N.
- [10] Development of first-in-class small molecule inhibitors of FLIP which activate caspase-8, the nodal regulator of apoptosis, necroptosis and pyroptosisCANCER RESEARCH, 2020, 80 (16)Longley, Daniel B.Higgins, CatherineFox, JenniferRoberts, Jamie Z.Boffey, RayWilliams, SophiePerrior, TrevorPage, Martin J.Harrison, Tim